PAR PHARM FDA Approval ANDA 209766

ANDA 209766

PAR PHARM

FDA Drug Application

Application #209766

Application Sponsors

ANDA 209766PAR PHARM

Marketing Status

Discontinued001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL360MG0DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-05-30STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209766
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"DILTIAZEM HYDROCHLORIDE","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"360MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/30\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-05-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.